Product Information

ZITUVIO 50 MG TABLET is a brand product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $10.0363 per EA under NDC 70710124103. Its NADAC has been published 70 times since Apr 23, 2025.

FDA first approved this application on Oct 18, 2023.

ZITUVIO 50 MG TABLET

Sitagliptin
$10.0363per EA

Strength

50 mg/1

NDC

70710124103

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

SITAGLIPTIN

Approval Type

New Drug (NDA)

FDA Application

NDA211566

FDA Approved

10/18/2023

On Market Since

11/30/2023

Pharmacological Classes

Dipeptidyl Peptidase 4 Inhibitor
Dipeptidyl Peptidase 4 Inhibitors

Price Statistics

The NADAC for ZITUVIO 50 MG TABLET has been published 70 times since Apr 23, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$10.0363 per EA
All-time high$10.0687 (Jul 16, 2025)
All-time low$10.0336 (Nov 19, 2025)
52-week high$10.0555
52-week low$10.0336
Median price$10.0412
Average price$10.0462
Largest weekly change-0.1% (Oct 22, 2025)
Weeks tracked70
Tracking sinceApr 23, 2025

Price History

1W

-0.0%

1M

-0.0%

3M

-0.0%

6M

-0.0%

1Y

-0.2%

3Y

N/A

5Y

N/A

All

-0.3%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Sitagliptin market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of ZITUVIO 50 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ZITUVIO 50 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $10.0363 per EA (NDC 70710124103), effective Aug 19, 2026.

How has the price of ZITUVIO 50 MG TABLET changed over time?

Over the history we have for it, the NADAC for ZITUVIO 50 MG TABLET has held within roughly two percent of its current level. It has been tracked across 70 weekly CMS publications since Apr 23, 2025.

What are the highest and lowest recorded NADAC prices for ZITUVIO 50 MG TABLET?

Since Apr 23, 2025, the NADAC for ZITUVIO 50 MG TABLET has ranged from a low of $10.0336 (Nov 19, 2025) to a high of $10.0687 (Jul 16, 2025), with a median of $10.0412 per EA.

Are there cheaper alternatives to ZITUVIO 50 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of ZITUVIO 50 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ZITUVIO 50 MG TABLET?

ZITUVIO 50 MG TABLET (NDC 70710124103) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a brand product.